Raquel Izumi
Founder chez VINCERX PHARMA, INC.
Fortune : 9 M $ au 31/03/2024
Profil
Raquel E.
Izumi is the founder.
She founded Acerta Pharma BV in 2013 as the Executive VP-Clinical Development.
She also founded Aspire Therapeutics LLC in 2011 as the Chief Scientific Officer.
Dr. Izumi is also the founder of Vincera Pharma, Inc., which was founded in 2018.
Currently, she holds the position of Independent Director at LifeSci Acquisition III Corp.
Dr. Izumi's former job was as the Senior Director-Clinical Development at Pharmacyclics LLC from 2010 to 2011.
She obtained a doctorate degree from the University of California, Los Angeles in 2000 and an undergraduate degree from the University of California, Santa Barbara in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VINCERX PHARMA INC
7,97% | 07/03/2024 | 1 704 413 ( 7,97% ) | 9 M $ | 31/03/2024 |
Postes actifs de Raquel Izumi
| Sociétés | Poste | Début |
|---|---|---|
| VINCERX PHARMA, INC. | Founder | 19/12/2018 |
LifeSci Acquisition III Corp.
 LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Director/Board Member | - |
Anciens postes connus de Raquel Izumi
| Sociétés | Poste | Fin |
|---|---|---|
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Founder | 01/05/2020 |
| Aspire Therapeutics LLC | Founder | 01/02/2013 |
| PHARMACYCLICS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2011 |
Vincera Pharma, Inc. /Old/
 Vincera Pharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Vincera Pharma, Inc. operates as a biopharmaceutical company. It develops and delivers medicines to patients. The company was founded by Ahmed Hamdy, Raquel Izumi, Tom Thomas, Stuart Hwang, and John Byrd and is headquartered in Santa Clara, CA. | Founder | - |
Formation de Raquel Izumi
| University of California, Los Angeles | Doctorate Degree |
| University of California, Santa Barbara | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VINCERX PHARMA, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
Vincera Pharma, Inc. /Old/
Vincera Pharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Vincera Pharma, Inc. operates as a biopharmaceutical company. It develops and delivers medicines to patients. The company was founded by Ahmed Hamdy, Raquel Izumi, Tom Thomas, Stuart Hwang, and John Byrd and is headquartered in Santa Clara, CA. | Health Technology |
| Aspire Therapeutics LLC | |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Finance |
